Invention Grant
- Patent Title: Liquid viral formulations
-
Application No.: US14693977Application Date: 2015-04-23
-
Publication No.: US09610309B2Publication Date: 2017-04-04
- Inventor: Matthew C. Coffey , Sarah Serl , Leo Pavliv
- Applicant: Oncolytics Biotech Inc.
- Applicant Address: CA Calgary, Alberta
- Assignee: Oncolytics Biotech Inc.
- Current Assignee: Oncolytics Biotech Inc.
- Current Assignee Address: CA Calgary, Alberta
- Agency: Kilpatrick Townsend & Stockton LLP
- Main IPC: C12N7/00
- IPC: C12N7/00 ; A61K39/12 ; A61K35/76 ; A61K39/00 ; A61K39/15 ; A61K35/765

Abstract:
Provided herein are liquid viral formulations useful for the stabilization and storage of viruses and methods of preparing these formulations. The liquid viral formulations described herein include a virus (e.g., a purified virus) and a non-viral composition including excipients and a liquid carrier. The formulations can be used, for example, to retain the infectivity or immunogenicity of viruses during periods of storage.
Public/Granted literature
- US20150224155A1 LIQUID VIRAL FORMULATIONS Public/Granted day:2015-08-13
Information query